← Leaderboards
Natalie Adel Afshari
Case Western Reserve University
$1,178,935
Attributed
$2,618,988
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $407.9K · FY2013–21$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,618,988 · 2
By mechanism
R01$2,618,988 · 2
Top collaborators
- Eugene Wei-Ming Yeo4 shared
- Sudha K Iyengar3 shared
- Joel M. Gottesfeld2 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Jianjie Ma$31,916,684
- Maria Hatzoglou$21,481,279
- Walter F Boron$16,230,123
- Alan David Levine$25,871,674
- Aaron Weinberg$13,644,444
Others in their field
Top investigators on “Tcf7l2 Gene”
- Struan F A Grant · Children'S Hosp Of Philadelphia$10,562,679
- Adrian Vella · Mayo Clinic Rochester$10,259,237
- Sonia Caprio · Yale University$8,840,586
- Boris Reizis · Columbia University Health Sciences$6,932,599
- Michael Boehnke · Broad Institute, Inc.$5,759,009
- Shalendar Bhasin · La Biomed Res Inst/ Harbor Ucla Med Ctr$5,714,858
Research focus
Tcf7l2 GeneBlindnessHereditary DiseaseSamplingAffectKeratoplastyFuchs&AposGeneticMolecularProteinsCorneal EndotheliumWomanProgramsBaseCorneaEndothelial DystrophyFunctional DisorderGenesAmyotrophic Lateral SclerosisBinding SitesCorneal DiseasesBinding ProteinsCell ModelAlternative Splicing
Grant awards (7)
Application of RNA-targeting Cas9 to Fuchs' dystrophy$322,405
R01 · FY2021 · EY
Application of RNA-targeting Cas9 to Fuchs' dystrophy$332,377
R01 · FY2020 · EY
Application of RNA-targeting Cas9 to Fuchs' dystrophy$391,677
R01 · FY2019 · EY
Application of RNA-targeting Cas9 to Fuchs' dystrophy$391,679
R01 · FY2018 · EY
Integrative Genetic Analyses in Fuchs Endothelial Corneal Dystrophy$386,487
R01 · FY2015 · EY
Integrative Genetic Analyses in Fuchs Endothelial Corneal Dystrophy$386,488
R01 · FY2014 · EY
Integrative Genetic Analyses in Fuchs Endothelial Corneal Dystrophy$407,875
R01 · FY2013 · EY